MR spectroscopy of prostate cancer. Initial clinical experience

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 4, 2005, Pages 523-530

  Squillaci, Ettore ^a   Manenti, G ^a   Mancino, S ^a   Carlani, M ^a   Di Roma, M ^a   Colangelo, V ^a   Simonetti, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Biopsy; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopic Imaging; Prostate; Prostatic cancer

Indexed keywords

CHOLINE; CREATINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; AGED, 80 AND OVER; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONICS;

EID: 31344436628     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Cancer Society, Inc. Estimated new cancer cases and deaths by gender: US 2004. Cancer Facts and Figures 2004:4.
2. Waterbor J.W., Bueschen A.J.: Prostate Cancer screening (United States). Cancer Causes Control 6:267-274, 1995.
3. Ikonen S., Karkkainen P., Kivisaari L., et al.: Magnetic resonance imaging of clinically localized prostatic cancer. J. Urol. 159:915-919, 1998.
4. Ellis J.H., Tempany C., Sarin M.S., Gatsonis C., Rifkin M.D., McNeil B.J.: MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR. 162:865-872, 1994.
5. Hricak H., White S., Vigneron D., et al.: Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 193:703-709, 1994.
6. Kurhanewicz J., Swanson M.G., Nelson S.J., Vigneron D.B.: Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. JMRI 16:451-463, 2002.
7. Hricak H., Dooms G.C., McNeal J.E. et al.: MR imaging of prostate gland: normal anatomy. AJR. Am. J. Roentgenol. 148:51-55, 1987.
8. Scheidler J., Hricak H., Vigneron D.B., et al.: Prostate cancer: localization with threedimensional proton MR spectroscopic imaging- clinicopathologic study. Radiology 213:473-480, 1999.
9. Stamey T.A., Mcneal J.E.: Adeno Carcinoma of the Prostate. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr (eds.). Campbell's Urology. Philadelphia, WB Saunders, 1992, 1159-1221.
10. Mettlin C.J., Black B., Lee F., Littrup P.J., DuPont A., Babaian R. et al.: Workgroup #2: screening and detection-reference range/clinical issues of PSA. Cancer 71:2679-2680, 1993.
11. Smith J.A., Scardino P.T., Resnick M.I., Hernandez A.D., Rose S.C., Egger M.J.: Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective multi-institutional trial. J. Urol. 157:902-906, 1997.
12. Olsson C.: Prostatic cancer. Kidney Int. 43:955-965, 1993.
13. Keetch D.W., Catalona W.J., Smith D.S.: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol. 151:1571-1574, 1994.
14. Ellis W.J., Brawer M.K.: Repeat prostate needle biopsy: who needs it? J. Urol. 153:1496-1498, 1995.
15. White S., Hricak H., Forstner R. et al.: Prostate cancer: Effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385-390, 1995.
16. Yu K.K., Scheidler J., Hricak H., et al.: Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481-488, 1999.
17. Coakley F.V., Kurhanewicz J., Lu Y., et al.: Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223:91-97, 2002.
18. Husband J.E., Padhani A.R., Macvicar A.D., Revell P.: Magnetic Resonance Imaging of Prostate Cancer: Comparison of Image Quality Using Endorectal and Pelvic Phased-Array Coils. Clinical Radiology 53:673-681, 1998.
19. Vigneron D.B., Males R., Noworolski S., et al.: 3D MRSI of prostate cancer: correlation with histologic grade (abstr). In: Proceedings of the Sixth Meeting of the International Society for Magnetic resonance in Medecine. Berkeley, California: International Society for Magnetic Resonance in Medicine: 487, 1998.
20. Sosna J., Pedrosa I., Dewolf W.C., Mahallati H., Lenkinski R.E., Rofsky N.M.: MR Imaging of the Prostate at 3 Tesla: Comparison of an External Phased-array Coil to Imaging with an Endorectal Coil at 1.5 Tesla. Acad. Radiol. 11:857-862, 2004.
21. Bloch B.N., Rofsky N.M., Baroni R.H., Marquis R.P., Pedrosa I., Lenkinski R.E.: 3 Tesla Magnetic Resonance Imaging of the Prostate with Combined Pelvic Phased-array and Endorectal coils: Initial Experience. Acad. Radiol. 11:863-867, 2004.
22. Futterer J.J., Scheenen T.W., Huisman H.J., et al.: Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate. Invest. Radiol. 39(11):671-680, 2004.
23. Kim H-W., Buckley D.L., Peterson D.L., et al.: In Vivo Prostate Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy at 3 Tesla Using a Transceive Pelvic Phased Array Coil. Invest. Radiol. 38:443-451, 2003.
24. Beyersdoff D., Taupitz M., Winkelmann B., et al.: Patients with a History of Elevated Prostate-Specific Antigen Levels and Negative Transrectal US-guided Quadrant or Sextant Biopsy Results: Value of MR Imaging. Radiology 224:701-706, 2002.
25. D'Amico A.V., Tempany C.M., Cormack R., et al.: Transperineal magnetic resonance image guided Prostate biopsy. J. Urol. 164:385-387, 2000.
26. Beyersdoff D., Bernd Hamm A.W., Lenk S., Loening S.A., Taupitz M.: MR Imaging-guided Prostate Biopsy with a Closed MR Unit at 1.5T: Initial Results. Radiology 234:576-581, 2005.